logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Figure TDI-3. Trend in estimated number of all clients entering treatment by primary drug used, from 2002 to 2007 [see all figures in this series...]

Part (i) Percentage distribution by primary drug


Countries included: Bulgaria, Czech Republic, Denmark, Germany, Ireland, Greece, Spain, Cyprus, Luxembourg, Hungary, Malta, Netherlands, Romania, Slovenia, Slovakia, Finland, Sweden, United Kingdom.

Missing data were interpolated for the respective countries by preserving the average year-on-year EU trend from available data. Altogether, 6 % of data points and 7 % of the total number of clients were interpolated.

Italian data was excluded because before 2005 it was not compatible with the TDI definition.

French data was omitted due to changes in reporting structures in 2006.

< A revision in the German Core Data Set and the Hungarian data collection system in 2008 may effect the comparability of 2007 values with earlier years.

Related links:

See also ‘General notes for interpreting data’ on the Explanatory notes and help page

See also Table TDI-102 and Figure TDI-1 part (ii)


Reitox national reports ST 34, ST 04 and ST 03 and TDI.

(see the help page for information about formats etc.)

Page last updated: Monday, 31 August 2009